Skip to main content
. 2017 Aug 1;7:6975. doi: 10.1038/s41598-017-07308-3

Figure 7.

Figure 7

Antibodies bind to modified NS1-WD peptide in dengue patients. (A) The OD of antibodies against NS1, modified NS1-WD peptide-conjugated BSA, C terminal NS1 (a.a. 305–314)-conjugated BSA and control peptide (Nonspecific peptide)-conjugated BSA in the sera of dengue patients (N = 67), as well as healthy donors (N = 26), was determined by ELISA. (B) The correlation of the OD of anti-NS1 (x-axis) and anti-modified NS1-WD peptide (y-axis) antibodies in the sera of dengue patients (N = 67). (C) The OD ratio of Abs binding to modified NS1-WD peptide to total NS1 Abs was significantly reduced in severe dengue patients’ sera (N = 17) compared to dengue with (N = 20) or without (N = 30) warning signs. *p < 0.05, **p < 0.01, ***p < 0.001. (D) The comparison of the OD of total NS1 Abs in dengue patients with different disease severity.